We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Role of the GAD2 Gene in Obesity Elucidated

By Biotechdaily staff writers
Posted on 21 Nov 2003
Researchers have found evidence that the chromosome 10 GAD2 gene has a direct role in determining an individual's likelihood to become obese.

GAD2 codes for the enzyme glutamic acid decarboxylase (GAD65), which catalyzes the production of a neurotransmitter (gamma-aminobutyric acid, or GABA) that interacts with a neuropeptide (NPY) in the hypothalamus to help stimulate appetite.

Investigators at the Imperial College London (UK; www.ic.ac.uk) compared genome-wide scans of 576 obese and 646 normal-weight French adults and identified two alleles of the GAD2 gene. More...
One allele was protective against obesity, while the other increased the risk of obesity. As explained in a paper published online on November 3, 2003, in the Public Library of Science (PloS) Biology, people carrying the GAD2 allele that increases the risk of obesity were significantly more likely to reveal an inability to control their food intake, and perceived high levels of hunger.

Senior author Dr. Philippe Froguel, a professor at the Imperial College London, explained, "Genetic factors alone can not explain the rapid rise in obesity rates, but they may provide clues to preventative and therapeutic approaches that will ease the health burden associated with obesity. Having identified this gene, it may be possible to develop a screening program to identify those who may be at risk of becoming obese later in life, and take effective preventative measures.”



Related Links:
Imperial College London

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Manual Pipetting Aid
Pipette Controllers macro
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.